Expanded phase I study of intratumoral Ad-RTS-hIL-12 plus oral veledimex: Tolerability and survival in recurrent glioblastoma.-MedSci.cn

Expanded phase I study of intratumoral Ad-RTS-hIL-12 plus oral veledimex: Tolerability and survival in recurrent glioblastoma.

Chiocca, EA; Yu, J; Phuphanich, S; Lukas, RV; Kumthekar, P; Yang, YJ; Zhou, Q; Buck, JY; Deary, A; Cai, HL; Barrett, JA; Cooper, LJN; Lebel, FM

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务